Aplastic Anemia News and Research

RSS
MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

Clinical trial uses personalized cellular therapy to treat GVHD complication of bone marrow transplant

Clinical trial uses personalized cellular therapy to treat GVHD complication of bone marrow transplant

Mount Sinai researchers reprogram blood cells into iPSCs to study genetic origins of MDS

Mount Sinai researchers reprogram blood cells into iPSCs to study genetic origins of MDS

Longer donor leukocyte telomere length linked to improved survival following HCT

Longer donor leukocyte telomere length linked to improved survival following HCT

SCCA's Fred Hutch Bone Marrow Transplant Program achieves higher survival rates

SCCA's Fred Hutch Bone Marrow Transplant Program achieves higher survival rates

Stem cell technologies market expected to show annual increase of 16.2% over 2010-2020

Stem cell technologies market expected to show annual increase of 16.2% over 2010-2020

Medac Pharma launches Rasuvo (methotrexate) injection for patients with RA, pJIA and psoriasis

Medac Pharma launches Rasuvo (methotrexate) injection for patients with RA, pJIA and psoriasis

Scientists identify gene mutation that causes aplastic anemia

Scientists identify gene mutation that causes aplastic anemia

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

Eleanor Roosevelt's cause of death and end of life issues examined during clinicopathological conference

Eleanor Roosevelt's cause of death and end of life issues examined during clinicopathological conference

CIBMTR recognizes SCCA's Fred Hutchinson Bone Marrow Transplant Program

CIBMTR recognizes SCCA's Fred Hutchinson Bone Marrow Transplant Program

Researchers discover pre-leukemic stem cell that triggers relapse in patients with AML

Researchers discover pre-leukemic stem cell that triggers relapse in patients with AML

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

FDA grants Breakthrough Therapy designation to GSK's Promacta/Revolade for treatment of cytopenias

FDA grants Breakthrough Therapy designation to GSK's Promacta/Revolade for treatment of cytopenias

Immunologists receive $4.8M grant to target multiple diseases by manipulating enzyme

Immunologists receive $4.8M grant to target multiple diseases by manipulating enzyme

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis